Urea, N-[3-[[(6,7-difluoro-2-quinoxalinyl)amino]methyl]phenyl]-N'-(4-phenoxyphenyl)- manufacturers
|
| | Urea, N-[3-[[(6,7-difluoro-2-quinoxalinyl)amino]methyl]phenyl]-N'-(4-phenoxyphenyl)- Basic information |
| | Urea, N-[3-[[(6,7-difluoro-2-quinoxalinyl)amino]methyl]phenyl]-N'-(4-phenoxyphenyl)- Chemical Properties |
| Boiling point | 591.2±50.0 °C(Predicted) | | density | 1.423±0.06 g/cm3(Predicted) | | pka | 13+-.0.70(Predicted) |
| | Urea, N-[3-[[(6,7-difluoro-2-quinoxalinyl)amino]methyl]phenyl]-N'-(4-phenoxyphenyl)- Usage And Synthesis |
| Uses | Anticancer agent 31 is a 1,3-diphenylurea quinoxaline derivative, and a anticancer agent. Anticancer agent 31 exhibits antitumor acitvity by arresting cell cycle at S phase and inducing apoptosis[1]. | | References | [1] Li GZ, et al. Synthesis and biological evaluation of novel 1,3-diphenylurea quinoxaline derivatives as potent anticancer agents. Med Chem Res 30,2021. 1496-1511. |
| | Urea, N-[3-[[(6,7-difluoro-2-quinoxalinyl)amino]methyl]phenyl]-N'-(4-phenoxyphenyl)- Preparation Products And Raw materials |
|